Mutational signature dynamics indicate SARS-CoV-2's evolutionary capacity is driven by host antiviral molecules. - Kieran D. Lamb; Martha M. Luka; Megan Saathoff; Richard J. Orton; My V. T. Phan; Matthew Cotten; Ke Yuan; David L. Robertson (PLoS Comput. Biol., 2024)